US Stock MarketDetailed Quotes

NXTC NextCure

Watchlist
  • 1.620
  • -0.050-2.99%
Close May 22 16:00 ET
  • 1.540
  • -0.080-4.94%
Post 19:48 ET
45.32MMarket Cap-710P/E (TTM)

About NextCure Company

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Company Profile

SymbolNXTC
Company NameNextCure
Listing DateMay 9, 2019
Issue Price15.00
Founded2015
CEOMr. Michael S. Richman
MarketNASDAQ
Employees82
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9000 Virginia Manor Road,Suite 200
CityBeltsville
ProvinceMaryland
CountryUnited States of America
Zip Code20705
Phone1-240-399-4900
Websitehttp://www.nextcure.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael S. Richman
  • President, Chief Executive Officer and Director
  • 1.04M
  • Dr. Timothy Mayer, PhD
  • Chief Operating Officer
  • --
  • Dr. Sol Langermann, PhD
  • Chief Scientific Officer
  • 681.59K
  • Steven P. Cobourn, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Han Myint, F.A.C.P.,M.D.
  • Chief Medical Officer
  • 697.93K
  • Kevin G. Shaw
  • Senior Vice President and General Counsel
  • --
  • Dr. Sourav Kundu, PhD
  • Senior Vice President, Development and Manufacturing
  • --
  • Dr. David S. Kabakoff,PhD
  • Chairman of the Board
  • 93.16K
  • Dr. John G. Houston, PhD
  • Independent Director
  • 61.66K
  • Dr. Ellen G. Feigal, M.D.
  • Independent Director
  • 61.66K
  • Dr. Elaine V. Jones, PhD
  • Independent Director
  • 67.47K
  • Chau Q. Khuong
  • Independent Director
  • 66.66K
  • Dr. Anne Borgman
  • Independent Director
  • 60.66K
  • Stephen W. Webster
  • Independent Director
  • 71.66K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg